Sat.Oct 31, 2020

article thumbnail

TaiGen Announces FDA Approval of IND for Its Flu Antiviral TG-1000

The Pharma Data

TAIPEI, Taiwan , Nov. 1, 2020 /PRNewswire/ — TaiGen Biotechnology Company, Limited (“TaiGen”) ( Taiwan : 4157) announced today that U.S. Food and Drug Administration (“FDA”) has approved the Investigation New Drug (IND) application for TG-1000, a novel treatment for influenza A and B. TG-1000 is a novel pan-influenza antiviral, which interrupts viral replication and transmission via a cap-snatching mechanism and is able to do this effectively against influenza-A, in

article thumbnail

New patent expiration for Pfizer Inc drug CAMPTOSAR

Drug Patent Watch

Annual Drug Patent Expirations for CAMPTOSAR Camptosar is a drug marketed by Pfizer Inc and is included in one NDA. It is available from one supplier. There are two patents…. The post New patent expiration for Pfizer Inc drug CAMPTOSAR appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Most Athletes With Heart Problems After COVID Can Return to Play

The Pharma Data

SATURDAY, OCT. 31, 2020 — COVID-19 may cause heart damage, which can be especially concerning to athletes eager to return to play as soon as they can. Myocarditis — inflammation in the heart usually caused by a viral infection — can lead to sudden death during exercise. With that in mind, the American College of Cardiology came up with some safety recommendations in May, which have now been revised. “This new set of recommendations is based on my and my fellow authorsR

article thumbnail

Vitamin B3 protects skin cells from the effects of UV exposure, new research finds

Scienmag

LUGANO, 31 October, 2020 – Research presented today at EADV’s 29th Congress, EADV Virtual, shows hope that a form of vitamin B3 could protect skin cells from the effects of ultraviolet (UV) exposure: the main risk factor for non-melanoma skin cancers (1). Researchers in Italy isolated cells (human primary keratinocytes) from the skin of patients […].

article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

Statement from the Chief Public Health Officer of Canada on November 1, 2020

The Pharma Data

OTTAWA, ON , Nov. 1, 2020 /CNW/ – In lieu of an in-person update to the media, Dr. Theresa Tam , Canada’s Chief Public Health Officer, issued the following statement today: “As the resurgence of COVID-19 activity continues in Canada , we are tracking a range of epidemiological indicators to monitor where the disease is most active, where it is spreading and how it is impacting the health of Canadians and public health, laboratory and healthcare capacity.

article thumbnail

Silencil Reviews – Groundbreaking New Report on Silencil For Tinnitus

BioTech 365

Long Island, NY, Oct. 31, 2020 (GLOBE NEWSWIRE) — Silencil is a recently released tinnitus supplement that has gone popular extremely fast. The product introduces a unique formulation consisting of several natural constituents.

article thumbnail

New research reveals risky sexual behavior and STIs are rising despite COVID-19 pandemic

Scienmag

LUGANO, 31 October, 2020 – New research (1) launched at the 29th EADV Congress, EADV Virtual, has found that despite the COVID-19 (SARS-CoV-2) lockdown restrictions, diagnosis of sexually transmitted infections (STIs), including gonorrhoea, secondary syphilis and mycoplasma genitalium (MG), have increased. The research, conducted in two main STI centres in Milan, Italy, compared the number […].